(Total Views: 742)
Posted On: 08/27/2022 4:49:01 PM
Post# of 148878
Novavax would have been the FIRST to have a vaccine approved, had not the FDA abruptly yanked the license for their contract manufacturing facility, and then THE VERY SAME DAY re-certified it for Pfizer to use. (Or maybe it was Moderna, it was 2 years ago and I don't remember which)
Then, a month later, when they found a factory in South Korea which was willing to make it, and which was ALREADY FDA-CERTIFIED, the FDA refused to certify it for Novavax, saying it had to be inspected in person. Then, they refused to send an inspector, because it would be "too dangerous" for 1 person to fly over there, potentially to save hundreds of thousands or millions of lives.
Eventually, many months later, when Novavax was finally allowed to manufacture the vaccine, guess what? Pfizer and Moderna had caught up to Novavax and they, and JNJ, won the race to be first with vaccines, and the resultant huge profits. Then, the FDA scheduled a meeting to consider their January 2022 data submission in.... JULY 2022. And then waited another 2 weeks to officially approve it.
But they were able to approve Pfizer's vaccine for teenagers in 1 day.
Oh -- Novavax is constantly being characterized as "failing to execute manufacturing" whenever you read an article about it. The failure, of course, is from the FDA screwing them.
How many people would not have died if Novavax had been able to get their vaccine out in October of 2020, if not for the FDA? How many people who were afraid of the JNJ and mRNA vaccines would have accepted the old-but-improved technology that Novavax uses?
So, if you think the FDA is going to magically decide to help CYDY, think again. They will continue slow-walking but there will come a point when they just can't do that any more -- as happened for Novavax -- and then we will see dramatic changes in stock price. Upward, I hope.
Novavax got approvals in 141 countries before the U.S. FDA gave it EUA.
I hope that CYDY learns from their example and DOES do clinical trials in places like Australia and the UK, rather than putting all the eggs in the FDA's basket.
Then, a month later, when they found a factory in South Korea which was willing to make it, and which was ALREADY FDA-CERTIFIED, the FDA refused to certify it for Novavax, saying it had to be inspected in person. Then, they refused to send an inspector, because it would be "too dangerous" for 1 person to fly over there, potentially to save hundreds of thousands or millions of lives.
Eventually, many months later, when Novavax was finally allowed to manufacture the vaccine, guess what? Pfizer and Moderna had caught up to Novavax and they, and JNJ, won the race to be first with vaccines, and the resultant huge profits. Then, the FDA scheduled a meeting to consider their January 2022 data submission in.... JULY 2022. And then waited another 2 weeks to officially approve it.
But they were able to approve Pfizer's vaccine for teenagers in 1 day.
Oh -- Novavax is constantly being characterized as "failing to execute manufacturing" whenever you read an article about it. The failure, of course, is from the FDA screwing them.
How many people would not have died if Novavax had been able to get their vaccine out in October of 2020, if not for the FDA? How many people who were afraid of the JNJ and mRNA vaccines would have accepted the old-but-improved technology that Novavax uses?
So, if you think the FDA is going to magically decide to help CYDY, think again. They will continue slow-walking but there will come a point when they just can't do that any more -- as happened for Novavax -- and then we will see dramatic changes in stock price. Upward, I hope.
Novavax got approvals in 141 countries before the U.S. FDA gave it EUA.
I hope that CYDY learns from their example and DOES do clinical trials in places like Australia and the UK, rather than putting all the eggs in the FDA's basket.
(10)
(0)Scroll down for more posts ▼
